LimeVest-Tawasol consortium amends purchase offer price of Alex NMC

Updated 8/29/2022 12:01:00 PM

Arab Finance: The price offered by the consortium comprising LimeVest Partners and Tawasol Holdings to purchase 74.08% of Alexandria New Medical Center’s (Alex NMC) (AMES) capital has been amended to 47.67 per share, according to a statement issued on August 29th.

The price has been modified to match the price of 11.536 million shares after the issuance of bonus shares.

Alex NMC had issued bonus shares to raise capital by 1.297 million.

The consortium previously offered to acquire 10.574 million shares out of Alex NMC’s capital share of 14.274 million at a price of EGP 52 per share.

Alex NMC is an Egypt-based public shareholding company engaged in the provision of medical diagnostic and treatment services in various medical fields.

The company focuses on hospital operations, which consists of a range of medical specializations, including gynecology, general surgery, and pediatrics, among others.

Related News